Cisatracurio Mylan Pharma

Medicinal product

(Invented) name

Cisatracurio Mylan Pharma

Active substance (s)

Cisatrakuris

Strength

2 mg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M03AC11, Cisatracurium

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-05-29

Date of renewal

Documents

2607_Cisatracurio Mylan Pharma 2mg-ml_inj_inf_tirp_PL_2025-05-29.docx

2607_Cisatracurio Mylan Pharma 2mg-ml_inj_inf_tirp_PZ_2025-05-29.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml tirpalo yra:	1 ml
Cisatrakuris	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117672	103775	1103775	ampulė	10 ml N5		Receptinis	LT/L/25/2607/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-05-29	Registruotas